Publicaciones en colaboración con investigadores/as de Universidad Complutense de Madrid (26)

2024

  1. Albumin Redox Modifications Promote Cell Calcification Reflecting the Impact of Oxidative Status on Aortic Valve Disease and Atherosclerosis

    Antioxidants, Vol. 13, Núm. 1

  2. Variable Penetrance and Expressivity of a Rare Pore Loss-of-Function Mutation (p.L889V) of Nav1.5 Channels in Three Spanish Families

    International Journal of Molecular Sciences, Vol. 25, Núm. 9

2023

  1. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  2. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

2022

  1. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study

    European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316

  2. VA-ECMO support in patients with refractory cardiogenic shock. A 6-year multicenter registry

    REC: CardioClinics, Vol. 57, Núm. 1, pp. 7-13

2021

  1. Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178

  2. Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC

    Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 438-448

2019

  1. Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations

    Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 749-759

  2. Impact of post-procedural minimal stent area on 2-year clinical outcomes in the SYNTAX II trial

    Catheterization and Cardiovascular Interventions, Vol. 93, Núm. 4, pp. E225-E234

2018

  1. A multicentre randomized pilot trial on the effectiveness of different levels of cooling in comatose survivors of out-of-hospital cardiac arrest: the FROST-I trial

    Intensive Care Medicine, Vol. 44, Núm. 11, pp. 1807-1815

  2. Characteristics and Outcomes of Patients Hospitalized With Suspected Acute Coronary Syndrome in Whom the Diagnosis is not Confirmed

    American Journal of Cardiology, Vol. 122, Núm. 10, pp. 1604-1609

  3. Safety and efficacy of cryoablation vs. radiofrequency ablation of septal accessory pathways: Systematic review of the literature andmeta-analyses

    Europace, Vol. 20, Núm. 8, pp. 1334-1342

  4. Safety and efficacy of intracoronary infusion of allogeneic human cardiac stem cells in patients with st-segment elevation myocardial infarction and left ventricular dysfunction a multicenter randomized, double-blind, and placebo-controlled clinical trial

    Circulation Research, Vol. 123, Núm. 5, pp. 579-589

2017

  1. C3G promotes a selective release of angiogenic factors from activated mouse platelets to regulate angiogenesis and tumor metastasis

    Oncotarget, Vol. 8, Núm. 67, pp. 110994-111011

  2. Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations

    Revista Espanola de Cardiologia, Vol. 70, Núm. 6, pp. 474-486

  3. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

    European Heart Journal, Vol. 38, Núm. 42, pp. 3124-3134

2016

  1. Cell expansion-dependent inflammatory and metabolic profile of human bone marrow mesenchymal stem cells

    Frontiers in Physiology, Vol. 7, Núm. NOV

2015

  1. A labdane diterpene exerts ex vivo and in vivo cardioprotection against post-ischemic injury: Involvement of AKT-dependent mechanisms

    Biochemical Pharmacology, Vol. 93, Núm. 4, pp. 428-439

  2. Prognosis and management of acute coronary syndrome in Spain in 2012: The DIOCLES study

    Revista Espanola de Cardiologia, Vol. 68, Núm. 2, pp. 98-106